Karyopharm Therapeutics shares owned by Connor, Clark & Lunn Investment Management
Quarter-by-quarter ownership of Karyopharm Therapeutics (KPTI) shares owned by Connor, Clark & Lunn Investment Management
from 13F filings
Historical chart of Connor, Clark & Lunn Investment Management investment in Karyopharm Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Karyopharm Therapeutics held by Connor, Clark & Lunn Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Karyopharm Therapeutics by Connor, Clark & Lunn Investment Management
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $62k | 71k | 0.87 |
2023-09-30 | $47k | 35k | 1.34 |
2023-06-30 | $67k | 38k | 1.79 |
2023-03-31 | $729k | 188k | 3.89 |
2022-12-31 | $1.5M | 432k | 3.40 |
2022-09-30 | $849k | 155k | 5.46 |
2022-06-30 | $207k | 46k | 4.50 |
2019-06-30 | $346k | 58k | 6.00 |
2019-03-31 | $765k | 131k | 5.84 |
2016-03-31 | $244k | 27k | 8.94 |
2015-12-31 | $545k | 41k | 13.26 |
2015-09-30 | $422k | 40k | 10.53 |
2015-06-30 | $1.2M | 46k | 27.20 |
2015-03-31 | $1.3M | 44k | 30.61 |
2014-12-31 | $412k | 11k | 37.45 |
More positions owned by Connor, Clark & Lunn Investment Management
View all positions for Connor, Clark & Lunn Investment Management